Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-01-24 Sale | 2025-01-27 6:15 pm | X4 Pharmaceuticals Inc | XFOR | Arbet-Engels Christophe Chief Medical Officer | 11,624 | $0.4546 | $5,284 | 14,207 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-12 Option Award | 2025-02-14 4:09 pm | N/A N/A | X4 Pharmaceuticals Inc | XFOR | Arbet-Engels Christophe Chief Medical Officer | 850,000 | $0 | 864,207 (Direct) | View |
| 2025-01-23 Option Award | 2025-01-27 6:15 pm | N/A N/A | X4 Pharmaceuticals Inc | XFOR | Arbet-Engels Christophe Chief Medical Officer | 25,831 | $0 | 14,207 (Direct) | View |
| 2024-02-13 Option Award(A) | 2024-02-28 5:52 pm | N/A 2034-02-13 | X4 Pharmaceuticals Inc | XFOR | Arbet-Engels Christophe Chief Medical Officer | 180,816 | $0 | 180,816 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-16 5:11 pm | N/A 2034-02-13 | X4 Pharmaceuticals Inc | XFOR | Arbet-Engels Christophe Chief Medical Officer | 475,831 | $0 | 475,831 (Direct) | View |
| 2023-08-31 Option Award | 2023-09-05 4:15 pm | N/A 2033-08-30 | X4 Pharmaceuticals Inc | XFOR | Arbet-Engels Christophe Chief Medical Officer | 1,250,000 | $1.28 | 1,250,000 (Direct) | View |